Target intelligence / Profile preview

Host immune and gut barrier pathways

Molecular classification
Other
01

Overview

Host immune and gut barrier pathways represent a complex network of biological processes rather than a single therapeutic target. These pathways involve the physical intestinal barrier, composed of epithelial cells and tight junction proteins like claudins and occludin, as well as the mucosal immune system, which includes specialized cells such as intraepithelial lymphocytes and dendritic cells. Their primary function is to maintain homeostasis by preventing the translocation of pathogens and toxins from the gut lumen into the systemic circulation while allowing for nutrient absorption and immune tolerance to commensal bacteria. Dysregulation of these pathways is a hallmark of various gastrointestinal and systemic conditions, including inflammatory bowel disease (IBD), where increased intestinal permeability (leaky gut) and aberrant immune activation lead to chronic inflammation. While many drugs target specific components within these pathways—such as TNF-alpha inhibitors or integrin blockers—the term itself describes a broad physiological system rather than a discrete protein or receptor.

Other names
Intestinal barrier functionGut-immune axisMucosal immune systemIntestinal permeability pathways
02

Mechanism of action

Not applicable as this is a collection of pathways rather than a single molecular target.

03

Biological functions

Immune responseBarrier functionHomeostasisSignal transductionCell-cell adhesion
04

Disease associations

InflammationInfectionAutoimmune diseaseInflammatory bowel diseaseCeliac diseaseIrritable bowel syndrome
05

Safety considerations

Systemic immunosuppressionDisruption of commensal microbiotaImpaired wound healingIncreased susceptibility to opportunistic infections
06

Biomarkers

ZonulinCalprotectinC-reactive proteinLipopolysaccharide-binding proteinIntestinal fatty acid-binding protein

Beyond the preview

Go deeper on Host immune and gut barrier pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host immune and gut barrier pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call